- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04000217
Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy
February 28, 2023 updated by: Carmen McLean, Palo Alto Veterans Institute for Research
A Randomized Control Trial Comparing Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy Delivered Online
The purpose of the study is to compare the efficacy of two different versions of a brief online exposure therapy program for PTSD: written versus verbal trauma narrative recounting in reducing PTSD symptom severity.
Both treatments will be delivered through an interactive online program with coaching from a trained peer support specialist.
Treatment will be a variable length, such that 4 to 8 sessions will be delivered, depending on each participants' rate of PTSD symptom recovery.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60642
- Prevail Health Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to read/write English
- Internet connection allowing stable access to the Vets Prevail website
- A clinically significant PCL-5 score of 31 or above.
Exclusion Criteria:
- A score on the suicidality item of the PHQ-9 of 3 or higher.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Written Exposure Therapy
Written exposure therapy (Sloan et al., 2012) is a brief evidence-based treatment for PTSD (US Dept. of VA & DoD, 2017), wherein patients are asked to write about their trauma memories for 30 minutes, with therapist instruction and feedback before and after each writing exercise.
|
In this study, written exposure therapy is delivered in an online format with coaching from trained peer support specialists.
Participants will complete 4-8 sessions, depending on their level of symptom reduction (i.e., allow for early termination when low symptom levels are achieved).
|
|
Active Comparator: Imaginal Exposure Therapy
Imaginal exposure therapy will involve verbal recounting of trauma memories for 30 minutes with therapist instruction and feedback before and after each recounting exercise.
|
Delivery of imaginal exposure in this study will mirror the procedures used in WET.
It will be delivered in an online format with coaching from trained peer support specialists.
Participants will complete 4-8 sessions, depending on their level of symptom reduction (i.e., allow for early termination when low symptom levels are achieved).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post Traumatic Stress Disorder CheckList for Diagnostic and Statistical Manual - 5 (PCL-5; Weathers, et al., 2013)
Time Frame: Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
Self report measure of PTSD symptoms.
A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items.
Higher scores indicate greater PTSD severity.
|
Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001).
Time Frame: Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
Self report measure of depression symptoms.
It is the 9-item measure that yields a total score of 0-27, with higher scores indicating greater depressive symptom severity.
|
Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
|
Brief version of the difficulties in emotion regulation scale (DERS-16; Bjureberg et al,. 2016)
Time Frame: Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
A 16-item self report measure of difficulties in emotion regulation.
Total scores on the DERS-16 can range from 16 to 80, with higher scores reflecting greater levels of emotion dysregulation.
|
Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
|
Work and Social Adjustment Scale (WSAS; Mundt et al., 2002)
Time Frame: Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
A 5-item self-report measure of work and social functioning and impact of symptoms.
Total scores range from 0-40 with higher scores indicating greater impairment.
|
Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2020
Primary Completion (Actual)
September 9, 2022
Study Completion (Actual)
September 9, 2022
Study Registration Dates
First Submitted
June 24, 2019
First Submitted That Met QC Criteria
June 25, 2019
First Posted (Actual)
June 27, 2019
Study Record Updates
Last Update Posted (Actual)
March 2, 2023
Last Update Submitted That Met QC Criteria
February 28, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 640C89370
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Written Exposure Therapy
-
Stanford UniversityNational Center for Complementary and Integrative Health (NCCIH); University...RecruitingPostpartum Care | Written Exposure Therapy | PTSD (Childbirth-Related) | Breathing TechniquesUnited States
-
Palo Alto Veterans Institute for ResearchThe University of Texas Health Science Center at San Antonio; Uniformed Services... and other collaboratorsNot yet recruitingPost Traumatic Stress Disorder | Written Exposure Therapy
-
University of ManchesterCompletedWritten Information | Written Info and Hearing Aid Reminder | Written Info and Planning on Hearing Aid Use | All MaterialsUnited Kingdom
-
Nanjing Medical UniversityUnknownVirtual Reality Exposure Therapy
-
Universitat Internacional de CatalunyaRecruitingSports Physical Therapy | Vibration; ExposureSpain
-
Tampere UniversityCompletedTreatment as Usual | Narrative Exposure TherapyFinland
-
Shanghai Mental Health CenterCompletedA Preliminary Study on the Intervention Effect of Virtual Reality Exposure Therapy on Fear of FlyingFear of Flying | Virtual Reality Exposure TherapyChina
-
Laboratoire de Psychologie des CognitionsUniversity Hospital, Strasbourg, France; ICube Laboratory - Team IGG; Ithaque... and other collaboratorsCompletedCocaine Use Disorder | Virtual Reality Exposure TherapyFrance
-
Stanford UniversityNational Cancer Institute (NCI)CompletedSmoking Cessation | MindCotine Virtual Reality Mindful Exposure TherapyUnited States
-
National Institute of Mental Health, Czech RepublicRecruitingObsessive-Compulsive Disorder | Cognitive Behavior Therapy | Virtual Reality Exposure Therapy | Virtual Reality Cognitive TrainingCzechia
Clinical Trials on Written Exposure Therapy
-
Columbia UniversityNational Center for PTSDTerminatedStroke | PTSD | Acute Coronary Syndrome | Cardiac Arrest | TIAUnited States
-
University of Texas Southwestern Medical CenterTexas Child Mental Healthcare Consortium (TCMHCC)Active, not recruitingPost-Traumatic Stress Disorder in Adolescence | PTSD - Post Traumatic Stress Disorder | PTSD and Trauma-related Symptoms | Pregnancy and PTSDUnited States
-
University of ManitobaCompletedPost Traumatic Stress DisorderCanada
-
Jesse McCannTerminatedStress Disorders, Post-Traumatic | Sexual Assault and RapeUnited States
-
University of Colorado, BoulderUniversity of Colorado, DenverCompletedLymphoproliferative Disorders | Anxiety | Metastatic Cancer | Solid Tumor Cancer | Post-traumatic Stress Symptoms | Fear of Cancer ProgressionUnited States
-
St. Joseph's Healthcare HamiltonRecruitingPosttraumatic Stress DisorderCanada
-
RANDBoston University; Clinical Directors NetworkActive, not recruiting
-
St. Joseph's Healthcare HamiltonNot yet recruitingPosttraumatic Stress Disorder (PTSD) | Borderline Personality Disorder (BPD)Canada
-
Peking UniversityRecruitingPTSD | Insomnia, SecondaryChina
-
University of North Carolina, Chapel HillUS Department of Veterans Affairs; Foundation of Hope, North CarolinaCompletedPost-traumatic Stress DisorderUnited States